scholarly article | Q13442814 |
P2093 | author name string | Doble A | |
Hugon J | |||
Terro F | |||
Burgevin MC | |||
Hubert JP | |||
P2860 | cites work | Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition | Q24313118 |
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis | Q28335672 | ||
A glutamate receptor regulates Ca2+ mobilization in hippocampal neurons | Q33673092 | ||
NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release | Q34289674 | ||
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis | Q34300016 | ||
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes | Q34306269 | ||
Excitatory amino acids as a final common pathway for neurologic disorders. | Q34321926 | ||
Glutamate neurotoxicity and diseases of the nervous system | Q34560997 | ||
Selective release of glutamate from cerebellar granule cells differentiating in culture. | Q36327939 | ||
Glutamate-induced increase in intracellular Ca2+ concentration in isolated hippocampal neurones | Q36414905 | ||
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity | Q36420529 | ||
Motor neuron disease (amyotrophic lateral sclerosis). | Q37627030 | ||
Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage | Q38201300 | ||
Excitotoxicity and motor neurone disease: a review of the evidence | Q40560831 | ||
Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis | Q40925698 | ||
The pharmacology and mechanism of action of riluzole | Q41263084 | ||
Glutamate, excitotoxicity and amyotrophic lateral sclerosis | Q41493319 | ||
Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity | Q41676626 | ||
Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action | Q42154486 | ||
Inability to restore resting intracellular calcium levels as an early indicator of delayed neuronal cell death | Q42513068 | ||
Agonist-activated cobalt uptake identifies divalent cation-permeable kainate receptors on neurons and glial cells | Q43604387 | ||
Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones | Q45263360 | ||
Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis | Q45291121 | ||
Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro | Q46097874 | ||
Perturbation of intracellular calcium and hydrogen ion regulation in cultured mouse hippocampal neurons by reduction of the sodium ion concentration gradient. | Q46479763 | ||
Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: a molecular determinant of selective vulnerability in amyotrophic lateral sclerosis | Q48046641 | ||
The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro. | Q48178207 | ||
Brain glutamate deficiency in amyotrophic lateral sclerosis | Q48180224 | ||
Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease | Q48241885 | ||
Modulation of N-methyl-D-aspartate receptor-mediated increases in cytosolic calcium in cultured rat cerebellar granule cells | Q48706385 | ||
The vulnerability of spinal cord neurons to excitotoxic injury: comparison with cortical neurons | Q48960636 | ||
Abnormal glutamate metabolism in amyotrophic lateral sclerosis. | Q51628220 | ||
Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. | Q54102342 | ||
Riluzole | Q56483801 | ||
Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS | Q57378339 | ||
Muscle-derived factors that support survival and promote fiber outgrowth from embryonic chick spinal motor neurons in culture | Q60215562 | ||
The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity | Q68454340 | ||
N-methyl-D-aspartate receptor-mediated calcium accumulation in neocortical neurons | Q70875527 | ||
Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures | Q71583358 | ||
Denervation increases a neurite-promoting activity in extracts of skeletal muscle | Q71693545 | ||
AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity | Q71698281 | ||
The human choline acetyltransferase gene encodes two proteins | Q71894573 | ||
Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors | Q72209261 | ||
The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray | Q72640800 | ||
Cortical neurones exhibiting kainate-activated Co2+ uptake are selectively vulnerable to AMPA/kainate receptor-mediated toxicity | Q73394604 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1421-1428 | |
P577 | publication date | 1998-12-01 | |
P1433 | published in | British Journal of Pharmacology | Q919631 |
P1476 | title | Effects of depolarizing stimuli on calcium homeostasis in cultured rat motoneurones | |
P478 | volume | 125 |
Q34104378 | A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? |
Q43742988 | AMPA-evoked acetylcholine release from cultured spinal cord motoneurons and its inhibition by GABA and glycine. |
Q40238809 | Effect of riluzole on Ca2+ movement and cytotoxicity in Madin-Darby canine kidney cells |
Q43681745 | Effect of riluzole on the acquisition and expression of amygdala kindling |
Q35770190 | Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology |
Q36285982 | Glutamate modulators as novel interventions for mood disorders |
Q43805021 | Intracellular activity of rat spinal cord motoneurons in slices |
Q73168777 | NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice |
Q44652546 | Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole |
Q34549829 | Riluzole But Not Melatonin Ameliorates Acute Motor Neuron Degeneration and Moderately Inhibits SOD1-Mediated Excitotoxicity Induced Disrupted Mitochondrial Ca2+ Signaling in Amyotrophic Lateral Sclerosis |
Q92277261 | The Effects of Riluzole on Cisplatin-induced Ototoxicity |
Q31789163 | The effect of riluzole treatment in rats on the survival of injured adult and grafted embryonic motoneurons |
Q33639170 | The role of excitotoxicity in neurodegenerative disease: implications for therapy |
Search more.